Key Takeaways on AOD 9604 Investigational status: AOD 9604 is not an FDA-approved medication for fat loss or any other indication, which is why medical supervision is essential
Important safety questions include product purity, dose accuracy, drug interactions, liver and kidney considerations, blood sugar changes, cardiovascular risk, pregnancy or breastfeeding status, and long-term exposure
Genetic factors can influence Vitamin B12 metabolism, necessitating personalized dosing protocols
Delivery format considerations AHK-Cu is water soluble
Incorporating growth hormone peptides for fat loss helps stimulate protein synthesis, ensuring that the weight lost comes predominantly from adipose tissue rather than skeletal muscle